KITTY SISK: Open Payments
NPI 1295885762 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,290 in 77 payments from 18 companies in 2025. Trend: 2023 $1,400 · 2024 $1,241 · 2025 $1,290
Food & beverage: $1,290
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 11 | $226 |
| Dexcom, Inc. | 11 | $162 |
| ABBVIE INC. | 11 | $150 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $128 |
| Lilly USA, LLC | 9 | $125 |
| GlaxoSmithKline, LLC. | 5 | $80 |
| SHIELD THERAPEUTICS INC | 4 | $70 |
| Abbott Laboratories | 3 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Sumitomo Pharma America, Inc. | 3 | $54 |
Products named: Veozah, Dexcom G6 Transmitter, Kerendia, JARDIANCE, MOUNJARO, ACCRUFER, TRELEGY ELLIPTA, FREESTYLE LIBRE.
Industry payments across GA — which companies pay providers there.
